[Review about psychopharmaceuticals for the use in children and adolescents with a respective license in Austria]

Neuropsychiatr. 2020 Mar;34(1):1-4. doi: 10.1007/s40211-020-00332-2. Epub 2020 Jan 23.
[Article in German]

Abstract

Given an indication for pharmacological treatment, prescribers can only draw from a rather limited number of substances with a label for the treatment of children and adolescents suffering from psychiatric disorders. In order to capture the currently available substances with such a label in Austria and to thus provide one element of informed patient education, the Austrian medicinal product index of the Austrian Federal Office for Safety in Health Care has been systematically searched. The resulting tables are being presented.

Keywords: Antidepressants; Antipsychotics; Child and youth psychiatry; Stimulants.

Publication types

  • Review

MeSH terms

  • Adolescent
  • Austria
  • Child
  • Drug Labeling / legislation & jurisprudence*
  • Humans
  • Mental Disorders / drug therapy*
  • Psychotropic Drugs / therapeutic use*

Substances

  • Psychotropic Drugs